Search Results - "KAEDA, J. S"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala→Gly), is the major polymorphic variant in tribal populations in India by KAEDA, J. S, CHHOTRAY, G. P, MASON, P. J, RANJIT, M. R, BAUTISTA, J. M, REDDY, P. H, STEVENS, D, NAIDU, J. M, BRITT, R. P, VULLIAMY, T. J, LUZZATTO, L

    Published in American journal of human genetics (01-12-1995)
    “…Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is usually found at high frequencies in areas of the world where malaria has been endemic. The frequency…”
    Get full text
    Journal Article
  2. 2

    Three major G6PD‐deficient polymorphic variants identified among the Mauritian population by Kotea, R., Kaeda, J. S., Yan, S. L. K., Sem Fa, N., Beesoon, S., Jankee, S., Ramasawmy, R., Vulliamy, T., Bradnock, R. W., Bautista, J., Luzzatto, L., Krishnamoorthy, R., Mason, P. J.

    Published in British journal of haematology (01-03-1999)
    “…We report the results of the first epidemiological study investigating glucose 6‐phosphate dehydrogenase (G6PD) deficiency among the heterogenous Mauritian…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia by Vulliamy, Tom J., Kaeda, Jaspal S., Ait‐Chafa, Dahlila, Mangerini, Rosa, Roper, David, Barbot, Jose, Mehta, Athul B., Athanassiou‐Metaxa, Luzzatto, Lucio, Mason, Philip J.

    Published in British journal of haematology (01-06-1998)
    “…We have determined the causative mutation in 12 cases of glucose‐6‐phosphate dehydrogenase deficiency associated with chronic non‐spherocytic haemolytic…”
    Get full text
    Journal Article
  5. 5

    New Glucose-6-Phosphate Dehydrogenase Mutations Associated With Chronic Anemia by Mason, P.J., Sonati, M.F., MacDonald, D., Lanza, C., Busutil, D., Town, M., Corcoran, CM, Kaeda, J.S., Stevens, D.J., Al-lsmail, S., Altay, C., Hatton, C., Lewis, D.S., McMullin, M.F., Meloni, T., Paul, B., Pippard, M., Prentice, A.G., Vulliamy, T.J., Luzzatto, L.

    Published in Blood (01-03-1995)
    “…We have identified the glucose-6-phosphate dehydrogenase mutations responsible for enzyme deficiency in nine individuals with chronic nonspherocytic hemolytic…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Severe hemolytic anemia associated with the homozygous state for an unstable hemoglobin variant (Hb Bushwick) by SRIVASTAVA, P, KAEDA, J. S, ROPER, D, VULLIAMY, T. J, BUCKLEY, M, LUZZATTO, L

    Published in Blood (01-09-1995)
    “…We have investigated a 13-year-old girl from first cousin parents who presented with severe hemolytic anemia. Hematologic studies showed unstable hemoglobin…”
    Get full text
    Journal Article
  8. 8

    Management of pregnancy when maternal blood has a very high level of fetal haemoglobin by Kaeda, J S, Prasad, K, Howard, R J, Mehta, A, Vulliamy, T, Luzzatto, L

    Published in British journal of haematology (01-10-1994)
    “…Fetal blood normally has a higher oxygen affinity than maternal blood because of the predominance of haemoglobin (Hb) F in the former and of Hb A in the…”
    Get more information
    Journal Article
  9. 9

    How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet by Bene, Marie C, Kaeda, Jaspal S

    Published in Haematologica (Roma) (01-08-2009)
    “…1 Immunologie, CHU & Nancy Université, France 2 Departamento de Hematologia, Centro Hospitalar de Coimbra, Portugal Correspondence: Marie Christine Béné,…”
    Get full text
    Journal Article
  10. 10

    Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib by Marin, David, Kaeda, Jaspal S., Andreasson, Catharina, Saunders, Sue M., Bua, Marco, Olavarria, Eduardo, Goldman, John M., Apperley, Jane F.

    Published in Cancer (01-05-2005)
    “…BACKGROUND A Phase I/II study was designed to show whether the addition of semisynthetic homoharringtonine (sHHT) would reduce the level of residual disease in…”
    Get full text
    Journal Article